"10.1371_journal.pone.0068640","plos one","2013-07-03T00:00:00Z","Gabriela Campanholle; Kristen Mittelsteadt; Shunsaku Nakagawa; Akio Kobayashi; Shuei-Liong Lin; Sina A Gharib; Jay W Heinecke; Jessica A Hamerman; William A Altemeier; Jeremy S Duffield","Division of Nephrology, University of Washington, Seattle, Washington, United States of America; Center for Lung Biology, Department of Medicine & Pathology, University of Washington, Seattle, Washington, United States of America; Institute of Stem Cell & Regenerative Medicine, University of Washington, Seattle, Washington, United States of America; Diabetes and Obesity Center of Excellence, University of Washington, Seattle, Washington, United States of America; Brigham & Womenâ€™s Hospital & Harvard Medical School, Boston, Massachusetts, United States of America; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States of America","Conceived and designed the experiments: GC AK JWH JAH WAA JSD. Performed the experiments: GC KM SN. Analyzed the data: GC KM SN SLL SAG JWH JAH WAA JSD. Contributed reagents/materials/analysis tools: AK SLL SAG JWH JAH WAA JSD. Wrote the paper: GC JSD.","This study was partly funded by a Genzyme research in progress (GRIP award to JSD). JSD is on the Scientific Advisory Board for Regulus Therapeutics and Promedior Inc. JSD is a co-founder of Muregen LLC. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","07","Gabriela Campanholle","GC",10,TRUE,6,3,9,2,TRUE,TRUE,FALSE,0,NA,FALSE
